English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

PI Industries offers robust growth opportunities in the high margin segment from the medium- to long-term perspectiveqrcode

Apr. 20, 2020

Favorites Print
Forward
Apr. 20, 2020

Follow

PI offers robust growth opportunities in the high margin segment from the medium- to long-term perspective while its debt-free balance sheet offers a high level of comfort, said Haitong. The brokerage is enthused about the company’s diversification into the high growth specialty chemicals business which offers a multi-year growth story.
 
Financials
 
PI Industries Ltd. key Products/Revenue Segments include Active Ingredients which contributed Rs 1920.50 crore to sales value (67.60 per cent of total sales), Formulations which contributed Rs 903.00 crore to sales value (31.78 per cent of total sales), Others which contributed Rs 17.40 crore to sales value (0.61 per cent of total sales)for the year ending March 31, 2019.
 
For the quarter ended December 31, 2019, the company reported consolidated sales of Rs 849.80 crore, down -6.35 per cent from last quarter sales of Rs 907.40 crore and up 20.11 per cent from last year same quarter sales of Rs 707.50 crore. The company reported net profit after tax of Rs 121.20 crore in the latest quarter.
 

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox